Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Kan tumorvækst Forudsiges Ved RGD-PET/MR af Vestibularis Schwannomer?

NCT03393689 is registered in ClinicalTrials.gov with Rigshospitalet, Denmark as lead sponsor.

NCT NCT03393689
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03393689 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Kan tumorvækst Forudsiges Ved RGD-PET/MR af Vestibularis Schwannomer?
Lead sponsor
Rigshospitalet, Denmark
Phase
Phase 2
Overall status
Unknown status
Start date
January 2, 2018
Completion date
January 2, 2021
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acoustic neuroma